Image

Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach

This study investigates Stereotactic Adaptive Radiation Therapy for Pancreatic Cancer

Recruiting
18 years and older
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates stereotactic adaptive radiation therapy for pancreatic cancer. The condition is borderline resectable, locally advanced, or medically inoperable pancreatic adenocarcinoma.

The study evaluates the effects of this therapy on gastrointestinal toxicity, overall survival, local control, quality of life, and workflow metrics.

  • Who can participate: Adults aged 18 and older with confirmed pancreatic adenocarcinoma that is borderline resectable, locally advanced, or medically inoperable may participate. Participants must have a good performance status and have received prior chemotherapy.
  • Study details: Participants will receive stereotactic adaptive radiation therapy. A placebo is not used in this study. The therapy is designed to manage pancreatic cancer with specific radiation doses.
Print
Study details
    Pancreatic Cancer

NCT05764720

Varian, a Siemens Healthineers Company

12 September 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.